JavaScript is disabled for your browser. Some features of this site may not work without it.
In vitro activities of the novel ceragenin, CSA-13, alone or in combination with colistin, tobramycin and ciprofloxacin against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
